Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,474 | 75,777 | 79,956 | 77,318 | 112,646 |
| Marketable Securities | 148,703 | 153,560 | 159,237 | 160,914 | 147,619 |
| Receivables | 6,360 | 7,261 | 5,684 | 7,360 | 6,226 |
| Inventories | 15,206 | 15,577 | 15,126 | 16,398 | 16,344 |
| TOTAL | $240,031 | $257,961 | $265,570 | $268,731 | $290,784 |
| Non-Current Assets | |||||
| PPE Net | 9,206 | 9,684 | 10,130 | 10,669 | 11,235 |
| Investments And Advances | 17,527 | 21,631 | 25,079 | 33,362 | 33,597 |
| Other Non-Current Assets | 460 | 460 | 460 | 460 | 460 |
| TOTAL | $27,193 | $31,775 | $35,669 | $44,491 | $45,292 |
| Total Assets | $267,224 | $289,736 | $301,239 | $313,222 | $336,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,732 | 4,601 | 2,549 | 1,008 | 4,553 |
| Accrued Expenses | 28,916 | 32,528 | 29,467 | 26,167 | 25,555 |
| TOTAL | $38,994 | $43,475 | $38,362 | $33,592 | $36,711 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,346 | 6,346 | 6,346 | 6,417 | 6,603 |
| Other Non-Current Liabilities | 2,438 | 2,527 | 2,615 | 2,704 | 2,787 |
| TOTAL | $47,634 | $49,247 | $50,859 | $52,472 | $54,079 |
| Total Liabilities | $86,628 | $92,722 | $89,221 | $86,064 | $90,790 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,349 | 21,203 | 21,185 | 21,160 | 21,137 |
| Common Shares | 213 | 212 | 212 | 212 | 211 |
| Retained earnings | -439,908 | -421,327 | -404,696 | -385,134 | -362,839 |
| Other shareholders' equity | -4,842 | -5,506 | -5,549 | -7,139 | -7,028 |
| TOTAL | $180,596 | $197,014 | $212,018 | $227,158 | $245,286 |
| Total Liabilities And Equity | $267,224 | $289,736 | $301,239 | $313,222 | $336,076 |